{
    "clinical_study": {
        "@rank": "1471", 
        "arm_group": {
            "arm_group_label": "Epilepsy Patients", 
            "arm_group_type": "Other", 
            "description": "This study has no arms, but will compare accuracy of seizure detection by the study device to simultaneously collected data of seizure detection by video EEG."
        }, 
        "brief_summary": {
            "textblock": "The seizure detection and warning system is an ambulatory system designed to monitor and\n      analyze EMG data to detect the onset of GTC seizures and to provide a warning signal to\n      alert caregivers that a seizure is occurring."
        }, 
        "brief_title": "Seizure Detection and Warning System for Epilepsy Patients", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Epilepsy", 
        "condition_browse": {
            "mesh_term": [
                "Epilepsy", 
                "Seizures"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Have a history of generalized tonic-clonic seizures, either primary GTC or partial\n             onset seizures with 2nd generalization.\n\n          -  Be admitted to a hospital for routine vEEG monitoring related to seizures.\n\n          -  Be ages 2-99.\n\n          -  Have an upper arm circumference which is adequate for proper fit of the EMG monitor\n             or the monitor with arm adapter (approximately 16 cm).\n\n          -  Be able to be discharged to a home with electrical power supply.\n\n          -  Be able to be discharged to a home where internet service via phone, broadband,\n             satellite or cellular phone service can be provided.\n\n          -  If female and of childbearing potential, have negative pregnancy test.\n\n          -  Can understand and sign written informed consent, or will have a parent or a legally\n             authorized representative (LAR) who can do so, prior to the performance of any study\n             assessments.\n\n          -  Subject and/or Primary Caregiver must be competent to follow all study procedures.\n\n          -  Able to read, speak, and understand English.\n\n        Exclusion Criteria:\n\n          -  Does not have a documented history of generalized seizures.\n\n          -  Has not had a GTC seizure within the last year AND is not expected to have a\n             reduction of anti-epileptic drugs during their hospital admission.\n\n          -  Intracranial EEG electrodes are being used\n\n          -  Upper arm circumference not adequate for proper fit of the EMG monitor even if the\n             arm adapter is used  (less than approximately 16cm).\n\n          -  If female, is pregnant.\n\n          -  Subject or Caregiver are unable to provide consent.\n\n          -  Subject or Caregiver not competent to follow home study procedures.\n\n          -  Homeless or home without power supply.\n\n          -  Resides in a home where internet service via phone, broadband, satellite or cellular\n             phone service cannot be provided.\n\n          -  Subject or Caregiver is unable to read, speak, or understand English."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "2 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01874600", 
            "org_study_id": "BS-0421"
        }, 
        "intervention": {
            "arm_group_label": "Epilepsy Patients", 
            "intervention_name": "Night Watch Seizure Detection Device and Warning System", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "December 11, 2013", 
        "location": {
            "contact": {
                "email": "jose.cavazos@brainsentinel.com", 
                "last_name": "Jose Cavazos, MD", 
                "phone": "855-275-5424"
            }, 
            "contact_backup": {
                "email": "patti.dawson@brainsentinel.com", 
                "last_name": "Patti Dawson, BS", 
                "phone": "855-275-5424", 
                "phone_ext": "102"
            }, 
            "facility": {
                "address": {
                    "city": "San Antonio", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "78232-1399"
                }, 
                "name": "Brain Sentinel"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Pivotal, Phase III Trial of Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients", 
        "overall_contact": {
            "email": "patti.dawson@brainsentinel.com", 
            "last_name": "Patti Dawson, BS", 
            "phone": "855-275-5424", 
            "phone_ext": "102"
        }, 
        "overall_official": [
            {
                "affiliation": "Brain Sentinel", 
                "last_name": "Jose' E Cavazos, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Children's Hospital of Philadelphia", 
                "last_name": "Dennis Dlugos, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "NYU Comprehensive Epilepsy Center", 
                "last_name": "Jaqueline French, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Emory University", 
                "last_name": "Edward Faught, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Mayo Clinic Jacksonville Florida", 
                "last_name": "William Tatum, DO", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Mayo Clinic Phoenix Arizona", 
                "last_name": "Katherine Noe, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Medical University of South Carolina", 
                "last_name": "Jonathan Halford, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Texas Health Presbyterian Hospital Dallas, Texas", 
                "last_name": "Jay Harvey, DO", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Thomas Jefferson University", 
                "last_name": "Michael Sperling, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Pennsylvania", 
                "last_name": "John Pollard, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary objective of the research is to determine the ability of the Night Watch\u2122 device to accurately detect GTC seizures in comparison to the recognized \"gold standard\" for seizure detection, video Electroencephalography (vEEG).The primary endpoint will be the sensitivity of GTC seizure detection (defined as within 30 seconds of motor manifestation via vEEG analysis) in a hospital setting.", 
            "measure": "Primary outcome is accuracy of device to detect GTC seizures when compared to video EEG.", 
            "safety_issue": "No", 
            "time_frame": "less than 1 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01874600"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The secondary objective is to assess the operation of the Night Watch\u2122 device when used in the subject's home and to compare the GTC seizure reporting of the device to a standard seizure diary completed by the subject/caregiver.", 
            "measure": "Comparison of study device to self reporting of seizures using a seizure diary.", 
            "safety_issue": "No", 
            "time_frame": "Less than 1 month"
        }, 
        "source": "Brain Sentinel", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Brain Sentinel", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}